Clinical trial
Experimental Vaccine for Malaria in Adults in Mali
NCT00343005 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00343005 |
|---|---|
| Title | Experimental Vaccine for Malaria in Adults in Mali |
| Official title | Double-Blind, Randomized, Controlled, Phase 1 Study of the Safety and Immunogenicity of AMA1-C1/Alhydrogel Vaccine for Plasmodium Falciparum Malaria, in Semi-Immune Adults in Doneguebougou, Mali |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum Malaria |
| Intervention type | Biological, Drug |
| Interventions | AMA1-C1, AMA1-C1/alhydrogel Malaria Vaccine |
| Enrollment | 54 |
| Start date | Apr 23, 2004 |
| Completion | Jan 22, 2008 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | Mali |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: